Anavex Life Sciences Corp. (AVXL) is currently at $11.14, up $2.51 or 29.08%
--Would be highest close since Feb. 7, 2023, when it closed at $11.75
--On pace for largest percent increase since Dec. 2, 2022, when it rose 35.85%
--Currently up two consecutive days; up 31.52% over this period
--Best two day stretch since the two days ending Dec. 2, 2022, when it rose 36.62%
--Up 17.76% month-to-date
--Up 19.66% year-to-date; on pace for best year since 2021, when it rose 221.11%
--Down 61.4% from its all-time closing high of $28.86 on June 28, 2021
--Up 24.47% from 52 weeks ago (Dec. 22, 2023), when it closed at $8.95
--Would be a new 52-week closing high
--Up 228.61% from its 52-week closing low of $3.39 on April 25, 2024
--Traded as high as $11.50; highest intraday level since Feb. 8, 2023, when it hit $11.90
--Up 33.26% at today's intraday high; largest intraday percent increase since Dec. 2, 2022, when it rose as much as 49.15%
All data as of 1:17:28 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 23, 2024 13:19 ET (18:19 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.